PrEP
36
8
10
14
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 36 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
29%
4 of 14 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 14 completed trials
Clinical Trials (36)
Pharmacy-based Provision of Pre-exposure Prophylaxis (PrEP) for Adolescent Girls and Young Women in Tanzania
Pharmacokinetic Study of Long-acting Antiretrovirals and Contraceptives in HIV
Linking Youth to Pre-Exposure Prophylaxis (PrEP) Services
DYnamic decisioN Support for IntegrAting PrEP in Clinics for Young People in Alabama and Botswana
PrEP-LANA (Pre-exposure Prophylaxis- Long-acting Novel Antiviral Agent)
HIV Pre-Exposure Prophylaxis (PrEP) Linkage With Immediate Medications in the Emergency Department Study
Using PrEP, Doing It for Ourselves
Bringing Medicines for HIV Prevention to a Family Planning Clinic
Hepatitis C Treatment to Prevent HIV, Initiate Opioid Substitution Therapy, and Reduce Risky Behavior
A Multi-Level Trauma-Informed Approach to Increase HIV Pre-exposure Prophylaxis Initiation Among Black Women
PrOTECT AL: PrEP Optimization Through Enhanced Continuum Tracking
HOTSPOT Study: Implement and Evaluate the PrEP (Pre-exposure Prophylaxis) Implementation Strategy
Clinic-based HIV Identification and Prevention Project Using Electronic Resources
Academic Detailing to Optimize PrEP Implementation in Pediatric Primary Care Settings: ADOPT-PrEP
Pre-Exposure Prophylaxis in the Emergency Department
Prevention ICONA Dedicated Ensemble
Tu'Washindi RCT: Adolescent Girls in Kenya Taking Control of Their Health
Pilot Mobile Medical Unit Study for I'm Fully Empowered4Her
Increasing PrEP Awareness and Demand Among Black Cisgender Women
Behavioral Intervention for PrEP Service Utilization Among Chinese MSM: A HAPA and CEI Integrated Model